Table 2. Prevalence of selected imaging signs of pulmonary ptMDR-TB vs. DS-TB in HIV(−) adults.
Study | Variables | MDR-TB | DS-TB | Variables | MDR-TB | DS-TB | |
---|---|---|---|---|---|---|---|
Chuchottaworn et al. (20) by CXR | Bilateral lungs | 52.2% | 14.7% | ≥2 lung zones | 59.8% | 23.5% | |
Joshi et al. (21) | Bilateral lungs | 92% | Bronchiectasis | 42% | |||
Chung et al. (22) | Bronchiectasis | 60% | 31% | ||||
Zahirifard et al. (24) | Bilateral lungs | 80% | |||||
Kim HC et al. (23) | Bronchiectasis | 79% | 55% | ||||
Chuchottaworn et al. (20) by CXR | Pleural effusion | 24.3% | 9.7% | Atelectasis | 14.5% | 4.1% | |
Joshi et al. (21) | Pleural involvement | 50% | |||||
Joshi et al. (21) | Pleural effusion | 28.6% | |||||
Chung et al. (22) | Pleural effusion | 57% | 27% | Lobar volume decrease | 71% | 46% | |
Kim HC et al. (23) | Pleural effusion | 17% | 23% | Lung destruction | 32% | 6% | |
Zahirifard et al. (24) | CXR: pleural thickening | 31% | |||||
Zahirifard et al. (24) | CXR: pleurisy | 14% | |||||
Zahirifard et al. (24) | CT: pleural involvement | 93% |